Login / Signup

Evaluation of symmetric dimethylarginine and creatinine in dogs with primary hypoadrenocorticism receiving long-term mineralocorticoid replacement therapy.

Jose I Casado DíazNadja S Sieber-RuckstuhlFelicitas S BorettiFederico FracassiClaudia E Reusch
Published in: The Veterinary record (2021)
Based on these data, the prevalence of CKD could be higher in dogs with PH receiving long-term mineralocorticoid replacement treatment than in the general dog population. However, additional studies with a larger number of dogs are needed to confirm it.
Keyphrases
  • replacement therapy
  • smoking cessation
  • chronic kidney disease
  • risk factors
  • electronic health record
  • big data
  • metabolic syndrome
  • machine learning
  • data analysis
  • artificial intelligence